apposters.com
UPMC
Edit

UPMC

https://www.upmc.com/
Last activity: 28.07.2026
Active
Categories: CareDoctorHealthTechInsurTechLifeMedTechNewsPersonalServiceTechnology
Every patient’s treatment experience is unique. An individual’s treatment outcome will depend on his or her personal circumstances, including age, general health, lifestyle, type and severity of disease, and other factors.

If you have a medical emergency, please call 911 or visit the nearest emergency department. For urgent referrals, please contact UPMC’s 24-hour physician referral service by calling 1-800-544-2500.
Likes
120.2K
Website visits
3.9M /mo.
Mentions
178
Persons
1
Location: United States, Pennsylvania, Pittsburgh
Employees: 10001+
Phone: 1-800-533
Total raised: $2.59M

Funding Rounds 1

DateSeriesAmountInvestors
21.07.2020Grant$2.59M-

Persons 1

DateFirst NameLast NameTitleLinkedIn
-CharlesSfeirArtificial...linkedin.c...

Mentions in press and media 178

DateTitleDescription
28.07.2026New Cholesterol Rules Add 21.5 Million Americans to Statin Eligibility ListBy Jackie Manning Published: Jul 28 2026, 8:46 PM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard
21.05.2026Guangzhou Lupeng/Newave Pharmaceutical Inc. Enrolled the First Patient in the Global Phase 3 ROCKET-CLL Trial Evaluating Rocbrutinib (LP-168) vs. Pirtobrutinib in R/R CLL/SLLHead-to-Head Study Highlights Rocbrutinib as the World's First Fourth-Generation Dual Covalent and Non-Covalent BTK Inhibitor Designed to Overcome Resistance Mutations GUANGZHOU, China and SAN FRANCISCO, May 21, 2026 /PRNewswire/ -- Lupeng ...
14.05.2026How Remote Patient Monitoring Can Alleviate Staffing Strain and Improve Healthcare DeliveryAndy Skinner, SVP of Operations at CareTrack As healthcare systems across the U.S. face unprecedented staffing shortages, overworked healthcare professionals are struggling to meet the needs of an ever-growing patient population. The pressu...
12.05.2026Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027Boston – MAY 12, 2026 – Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases and obesity, today announced completion of patient enrollment in the pivotal Phase 3 ARISE trial evalu...
20.04.2026JAMA Study: UPMC ‘Night Shift’ Video Game Reduces Trauma Under-Triage in Older AdultsNightshift Video Game What You Should Know: Research Data: New research published in JAMA suggests that video games may be more than just entertainment—they could be a life-saving tool for emergency medicine. A study led by UPMC and the Uni...
21.03.2026RAAPID Secures New Funding: Advancing Transparent AI in Healthcare ComplianceRAAPID, an AI-powered risk adjustment platform, secured additional Series A funding. UPMC Enterprises joined M12 in backing the Louisville-based company. RAAPID's Neuro-Symbolic AI links every diagnosis to clear clinical evidence. This appr...
19.03.2026RAAPID: Series-A Extension Raised To Scale Neuro-Symbolic AI Medical Coding PlatformRAAPID, an AI-powered risk adjustment company, announced it has secured an extension to its Series-A funding round with participation from UPMC Enterprises, the innovation and venture arm of UPMC. The investment builds on prior backing from...
18.03.2026RAAPID Raises Additional Series A Investment from UPMC EnterprisesRAAPID, Inc., a Louisville, Kentucky-based developer of an AI-powered risk adjustment platform for healthcare, raised an additional Series A investment from UPMC Enterprises, the venture capital arm of UPMC. The funding round follows previo...
03.03.2026BrainCheck Secures $13M to Advance AI Cognitive Care InfrastructureBrainCheck recently raised $13 million in Series A funding. This investment propels its AI-assisted cognitive care platform forward. The company aims to expand infrastructure, enhancing patient monitoring and population-scale deployment. It...
02.03.2026M&A: DoseSpot and Arrive Health Merge to Form Interra Health, Advancing ePrescribing Price TransparencyWhat You Should Know The Deal: Healthcare tech companies DoseSpot and Arrive Health have officially merged to form Interra Health. The Backers: The deal is backed by Bain Capital Tech Opportunities as the majority owner, with PSG (DoseSpot’...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In